drug
cabotegravir + rilpivirine LA
Marketedupdated 3mo agoby ViiV Healthcare Company
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 5all catalysts(2)
drug expiry · 1
Trials studying cabotegravir + rilpivirine LA
- phase4Study Using CABENUVA™ for the Treatment of Human Immunodeficiency Virus (HIV)-1, Administered in Infusion Centers (IC) or Alternate Sites of Administration (ASA) in the United States (U.S.)
- N/ACabenuva Injection Tracking in CHORUS
- —Chemsex Health Evaluation With Extended Release System for HIV Treatment
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 2m ago
Found something off?
comments(0)
5-min edit window · permanent after that